Clinical Trials Logo

Clinical Trial Summary

In this study, we aim to establish a prospective cohort of patients with endoscopically and histologically confirmed intestinal metaplasia, collect gastric mucosal tissue samples from this cohort, and follow the development of gastric cancer over time.


Clinical Trial Description

Patients visiting Seoul National University Hospital, who have previously received an incidental diagnosis of intestinal metaplasia during a prior gastroscopy examination, will be considered as potential candidates for this study. Upon obtaining their informed consent to participate, the initial endoscopy procedure will involve the collection of biopsies to ensure an accurate histological diagnosis of intestinal metaplasia. These biopsies will be taken from the antrum and body of the stomach, according to the protocol of the updated Sydney system, to pathologically diagnose the extent and severity of intestinal metaplasia. One to two pieces of tissue remaining from this diagnostic process will be retained for future analysis. Subsequently, patients will be followed up on an outpatient basis to track the development of gastric cancer through routine screening endoscopies. In cases where patients develop gastric cancer, a comparative analysis will be conducted with those who do not develop gastric cancer, to determine the differences in expression of markers in the gastric mucosal tissue that was collected during the initial endoscopy. Our ultimate aim is to identify potential biomarkers that may serve as predictive indicators for the development of gastric cancer in patients with a preexisting diagnosis of intestinal metaplasia. ;


Study Design


Related Conditions & MeSH terms

  • Intestinal Metaplasia of Gastric Mucosa
  • Metaplasia

NCT number NCT06075199
Study type Observational [Patient Registry]
Source Seoul National University Hospital
Contact Soo-Jeong Cho, MD, PhD
Phone 02-2072-4073
Email crystal5@snu.ac.kr
Status Recruiting
Phase
Start date September 13, 2023
Completion date June 30, 2033

See also
  Status Clinical Trial Phase
Recruiting NCT05459428 - Artificial Intelligence Confocal Laser Endomicroscopy for Real-time Assessment of Gastric Cancer Risk.
Recruiting NCT04191551 - The GAstric Precancerous Conditions Study
Recruiting NCT05459610 - Automatic Evaluation of the Extent of Intestinal Metaplasia With Artificial Intelligence
Recruiting NCT05464108 - Validation The Artificial Intelligence System for Automatic Evaluation of the Extent of Intestinal Metaplasia
Not yet recruiting NCT04251403 - Novel Approach to Surveillance of Gastric Lesions Early Phase 1